TLR4/ROS/miRNA-21 Pathway Underlies Lipopolysaccharide Instructed Primary Tumor Outgrowth in Lung Cancer Patients

Overview

Journal Oncotarget

Specialty Oncology

Date 2016 Jun 11

PMID 27286259

Citations 21

Authors

Xianqi Zhang

Chunhong Wang

Shan Shan

Xiyu Liu

Zhongmin Jiang

Tao Ren

Affiliations

Soon will be listed here.

Abstract

Activation of Toll-like receptor 4 (TLR4) signaling in human lung cancer with lipopolysaccharide (LPS) enhances tumor progression. However, whether primary human lung cancer outgrowth could respond to LPS and underlying mechanisms are unclear. Here we determined that TLR4 activation with LPS promoted outgrowth of primary human lung cancer cells in vitro and in vivo. Mechanistically, LPS stimulation increased expression levels of microRNA-21 (miR-21) in primary human lung cancer cells. Inhibition of miR-21 blocked the enhanced lung cancer growth induced by LPS in vitro and in vivo. Up-regulation of miR-21 promoted outgrowth of primary human lung cancer. Down-regulation of miR-21 limited primary human lung cancer outgrowth. Further, TLR4 activation in primary human lung cancer cells increased their ROS levels. Scavenge of ROS abrogated the up-regulation of miR-21 in primary human lung cancer cells and attenuated LPS-induced outgrowth. For in vivo relevance, expression of TLR4 was correlated with miR-21 expression and ROS production in freshly isolated, untreated primary human lung cancer cells. These findings demonstrate an essential role of TLR4/ROS/miR-21 pathway in LPS-induced outgrowth of primary human lung cancer. Our study connected a framework of innate signaling, oxidative stress and microRNA in tumor immunity and provided clues for developing new therapeutics for lung cancer.

Citing Articles

The crosstalk between non-coding RNAs and oxidative stress in cancer progression.

Sun Q, Lei X, Yang X Genes Dis. 2025; 12(3):101286.

PMID: 40028033 PMC: 11870203. DOI: 10.1016/j.gendis.2024.101286.

miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer.

Chakrabortty A, Patton D, Smith B, Agarwal P Genes (Basel). 2023; 14(7).

PMID: 37510280 PMC: 10378777. DOI: 10.3390/genes14071375.

Mitophagy bridges DNA sensing with metabolic adaption to expand lung cancer stem-like cells.

Liu Z, Shan S, Yuan Z, Wu F, Zheng M, Wang Y EMBO Rep. 2022; 24(2):e54006.

PMID: 36416244 PMC: 9900345. DOI: 10.15252/embr.202154006.

Deviations in MicroRNA-21 Expression Patterns Identify a Therapeutic Target for Diabetic Wound Healing.

Idlett-Ali S, Liechty K, Xu J J Immunobiol. 2022; 6(1).

PMID: 36282999 PMC: 9583731.

Prognostic Significance of TLR2, SMAD3 and Localization-dependent SATB1 in Stage I and II Non-Small-Cell Lung Cancer Patients.

Durslewicz J, Klimaszewska-Wisniewska A, Jozwicki J, Antosik P, Smolinska-Switala M, Gagat M Cancer Control. 2021; 28:10732748211056697.

PMID: 34818944 PMC: 8640983. DOI: 10.1177/10732748211056697.

References

Sheedy F, Palsson-McDermott E, Hennessy E, Martin C, OLeary J, Ruan Q . Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol. 2009; 11(2):141-7. DOI: 10.1038/ni.1828. View

Sullivan L, Chandel N . Mitochondrial reactive oxygen species and cancer. Cancer Metab. 2015; 2:17. PMC: 4323058. DOI: 10.1186/2049-3002-2-17. View

Feng J, Li A, Deng J, Yang Y, Dang L, Ye Y . miR-21 attenuates lipopolysaccharide-induced lipid accumulation and inflammatory response: potential role in cerebrovascular disease. Lipids Health Dis. 2014; 13:27. PMC: 3922422. DOI: 10.1186/1476-511X-13-27. View

Wang J, Jeelall Y, Ferguson L, Horikawa K . Toll-Like Receptors and Cancer: MYD88 Mutation and Inflammation. Front Immunol. 2014; 5:367. PMC: 4116802. DOI: 10.3389/fimmu.2014.00367. View

Guo Q, Zhang H, Zhang L, He Y, Weng S, Dong Z . MicroRNA-21 regulates non-small cell lung cancer cell proliferation by affecting cell apoptosis via COX-19. Int J Clin Exp Med. 2015; 8(6):8835-41. PMC: 4538100. View

Remark R, Becker C, Gomez J, Damotte D, Dieu-Nosjean M, Sautes-Fridman C . The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome. Am J Respir Crit Care Med. 2014; 191(4):377-90. PMC: 5447326. DOI: 10.1164/rccm.201409-1671PP. View

Grivennikov S, Greten F, Karin M . Immunity, inflammation, and cancer. Cell. 2010; 140(6):883-99. PMC: 2866629. DOI: 10.1016/j.cell.2010.01.025. View

Liochev S . Reactive oxygen species and the free radical theory of aging. Free Radic Biol Med. 2013; 60:1-4. DOI: 10.1016/j.freeradbiomed.2013.02.011. View

Costa A, Scholer-Dahirel A, Mechta-Grigoriou F . The role of reactive oxygen species and metabolism on cancer cells and their microenvironment. Semin Cancer Biol. 2014; 25:23-32. DOI: 10.1016/j.semcancer.2013.12.007. View

10.

Ray P, Huang B, Tsuji Y . Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012; 24(5):981-90. PMC: 3454471. DOI: 10.1016/j.cellsig.2012.01.008. View

11.

Li D, Jin Y, Sun Y, Lei J, Liu C . Knockdown of toll-like receptor 4 inhibits human NSCLC cancer cell growth and inflammatory cytokine secretion in vitro and in vivo. Int J Oncol. 2014; 45(2):813-21. DOI: 10.3892/ijo.2014.2479. View

12.

Tartour E, Zitvogel L . Lung cancer: potential targets for immunotherapy. Lancet Respir Med. 2014; 1(7):551-63. DOI: 10.1016/S2213-2600(13)70159-0. View

13.

Romero-Cordoba S, Salido-Guadarrama I, Rodriguez-Dorantes M, Hidalgo-Miranda A . miRNA biogenesis: biological impact in the development of cancer. Cancer Biol Ther. 2014; 15(11):1444-55. PMC: 4622859. DOI: 10.4161/15384047.2014.955442. View

14.

Yang Y, Meng H, Peng Q, Yang X, Gan R, Zhao L . Downregulation of microRNA-21 expression restrains non-small cell lung cancer cell proliferation and migration through upregulation of programmed cell death 4. Cancer Gene Ther. 2014; 22(1):23-9. DOI: 10.1038/cgt.2014.66. View

15.

Ling M, Li Y, Xu Y, Pang Y, Shen L, Jiang R . Regulation of miRNA-21 by reactive oxygen species-activated ERK/NF-κB in arsenite-induced cell transformation. Free Radic Biol Med. 2012; 52(9):1508-18. DOI: 10.1016/j.freeradbiomed.2012.02.020. View

16.

Tutar Y . miRNA and cancer; computational and experimental approaches. Curr Pharm Biotechnol. 2014; 15(5):429. DOI: 10.2174/138920101505140828161335. View

17.

Shen L, Wan Z, Ma Y, Wu L, Liu F, Zang H . The clinical utility of microRNA-21 as novel biomarker for diagnosing human cancers. Tumour Biol. 2014; 36(3):1993-2005. DOI: 10.1007/s13277-014-2806-z. View

18.

Liu X, Pei C, Yan S, Liu G, Liu G, Chen W . NADPH oxidase 1-dependent ROS is crucial for TLR4 signaling to promote tumor metastasis of non-small cell lung cancer. Tumour Biol. 2015; 36(3):1493-502. DOI: 10.1007/s13277-014-2639-9. View

19.

Elinav E, Nowarski R, Thaiss C, Hu B, Jin C, Flavell R . Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013; 13(11):759-71. DOI: 10.1038/nrc3611. View

20.

Bremnes R, Al-Shibli K, Donnem T, Sirera R, Al-Saad S, Andersen S . The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer. J Thorac Oncol. 2010; 6(4):824-33. DOI: 10.1097/JTO.0b013e3182037b76. View